Effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureus.

Anterior nares cultures from 664 hospital personnel identified 165 (24.8%) as carriers of Staphylococcus aureus. Persistent carriers (17.8%) were identified and randomly assigned to one of four treatment groups: rifampin (600 mg once a day for 5 days), bacitracin ointment (topically applied three ti...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	McAnally, T P, Lewis, M R, Brown, D R
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1984
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185544/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6732212/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.25.4.422
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!